1,3,5-TRIAZINE-2,4,6-TRIAMINE COMPOUND OR PHARMACEUTICAL ACCEPTABLE SALT THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
申请人:HanAll Biopharma Co., Ltd.
公开号:EP2197858B1
公开(公告)日:2014-07-02
SULFONYLUREA MODULATORS OF ENDOTHELIN RECEPTOR
申请人:Rao Tadimeti
公开号:US20110082151A1
公开(公告)日:2011-04-07
The present invention relates to new sulfonylurea modulators of endothelin receptor activity, pharmaceutical compositions thereof, and methods of use thereof.